NCT00397397

Brief Summary

We wish to determine the best treatment for expulsion of lower ureteral stones. Which of the three major treatment protocols is the best treatment of conservative management of ureteral stones?

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2007

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 9, 2006

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2007

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2007

Completed
Last Updated

November 9, 2006

Status Verified

November 1, 2006

First QC Date

November 8, 2006

Last Update Submit

November 8, 2006

Conditions

Urinary Calculi

Keywords

Urinary CalculiRowatinexAlfuzosinDrug Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of lower ureter (urinary calculi) up to 8mm
  • Must be able to swallow tablets

You may not qualify if:

  • Sensitivity to Alfuzosin and Rowatinex
  • Pregnant and breastfeeding women
  • Single kidney
  • Obstructing stone
  • Renal failure creatinine up to 1.8 mg/dl
  • Patients using various alpha blockers
  • Liver failure
  • Fever higher than 38 C
  • UTI
  • Syncope or hypotension
  • Patients treated with PDE5
  • Patients treated with inhibitor CYP3A4
  • Patients refusing participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hillel Yaffe Medical Center

Hadera, 38100, Israel

Location

MeSH Terms

Conditions

Urinary Calculi

Condition Hierarchy (Ancestors)

UrolithiasisUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Gabriel Faragi

    Urology Department, Hillel Yaffe Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
OTHER
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

November 8, 2006

First Posted

November 9, 2006

Study Start

January 1, 2007

Study Completion

March 1, 2007

Last Updated

November 9, 2006

Record last verified: 2006-11

Locations

IL(1)